Public Trust in Genetic Engineering Regulation

Introduction

Public trust in genetic engineering regulation refers to the confidence that citizens place in government authorities responsible for regulating genetically modified organisms (GMOs), gene-editing technologies and biotechnology products. Such trust depends on scientific integrity, transparency, public participation, independent risk assessment and accountability.

Genetic engineering may offer benefits such as improved agricultural productivity, disease-resistant crops and advanced medical treatments. However, concerns about environmental harm, food safety, biodiversity and corporate influence may reduce public confidence when regulatory decisions are made without adequate explanation or disclosure.

In India, public trust in genetic engineering regulation is closely connected with the constitutional right to a safe environment, the precautionary principle and the public trust doctrine.

Legal Framework

The primary regulatory framework for GMOs in India is provided by the Environment (Protection) Act, 1986, and the 1989 Rules on the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms, Genetically Engineered Organisms or Cells.

The Genetic Engineering Appraisal Committee (GEAC) considers proposals involving environmental release of genetically engineered organisms. The Review Committee on Genetic Manipulation (RCGM) monitors relevant research and safety-related activities.

The constitutional principles relevant to public trust include:

Article 14: Regulatory decisions must be fair, reasonable and non-arbitrary.

Article 21: Protects life and has been interpreted to include the right to a safe and healthy environment.

Article 19(1)(a): Supports freedom of expression and access to information necessary for informed public debate.

Article 48A: Directs the State to protect and improve the environment.

Article 51A(g): Places a fundamental duty on citizens to protect and improve the natural environment.

Public confidence is strengthened when regulatory authorities disclose relevant scientific information, explain their decisions and provide meaningful opportunities for stakeholder participation.

Case Laws

1. Gene Campaign v. Union of India (2024 INSC 545)

The Supreme Court considered challenges to the approval granted for environmental release of genetically modified mustard, DMH-11. The Court delivered separate opinions, but both judges agreed that decisions of GMO regulatory bodies are subject to judicial review.

The Court directed the Union Government to formulate a national policy on GM crops through consultation with experts, State Governments and representatives of farmers. The judgment also addressed public disclosure of scientific studies, regulatory transparency and the importance of public participation.

Indian Kanoon+2

This case demonstrates that public trust in biotechnology regulation depends on transparent scientific assessment, accountable decision-making and meaningful stakeholder consultation.

2. M.C. Mehta v. Kamal Nath (1997) 1 SCC 388

The Supreme Court recognised the public trust doctrine, under which the State holds certain natural resources in trust for the public. The State must protect these resources and cannot use its authority in a manner that unjustifiably harms public interests.

Although the case concerned environmental resources rather than genetic engineering, the doctrine is relevant to the protection of biodiversity and genetic resources. Regulatory authorities must consider environmental consequences and the interests of future generations when approving activities involving engineered organisms.

3. Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and the polluter-pays principle as essential components of Indian environmental law.

The precautionary principle requires authorities to take preventive measures where there is a credible risk of serious environmental harm, even if scientific certainty is incomplete. This principle is particularly relevant to genetic engineering because some ecological consequences may be difficult to predict or reverse.

Factors Affecting Public Trust

Public trust may be weakened by:

Inadequate disclosure of biosafety data and risk assessments.

Conflicts of interest within regulatory bodies.

Limited participation by farmers, consumers and affected communities.

Unclear responsibility for environmental or health-related harm.

Insufficient monitoring after approval.

Failure to explain the scientific basis of regulatory decisions.

These concerns can be addressed through independent scientific review, public disclosure of relevant information, transparent consultation, clear liability rules and continuing monitoring.

Conclusion

Public trust is essential to the legitimacy and effectiveness of genetic engineering regulation. Regulatory authorities must balance scientific innovation with public health, environmental protection and democratic accountability. The decisions in Gene Campaign, M.C. Mehta v. Kamal Nath and Vellore Citizens’ Welfare Forum demonstrate the importance of transparency, public participation, the public trust doctrine and precautionary safeguards. A trustworthy regulatory system should not rely solely on technical approval; it must also provide clear reasons, accessible information and meaningful opportunities for public scrutiny.